The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the impact of botulinum toxin treatment in quality of life(QoL) in cervical dystonia patients

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Roongroj Bhidayasiri
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• aged ≥ 18 years to 75 years

• Subjects requiring treatment for a clinical diagnosis of cervical dystonia

• Willing to provide written informed consent before any study-related procedures.

Exclusion Criteria:

• Patients with pure anterocollis

• Patients with an anaphlyactic response history to botulinum toxin type A.

• Patients who have been treated with botulinum toxin type A within 3 month.

• Females who are pregnant, planning pregnancy, unable to use contraception or lactating.

• Any medical condition that may put the subject at increased risk with exposure to botulinum toxin at the discrimination of investigators.